The Brazilian Ministry of Health recommends the performance of serological tests in patients with clinical signs of Sexually Transmitted Diseases. However, data are lacking to affirm the necessity of testing these patients for human T-lymphotropic virus type 1 or type 2. This is a cross-sectional study with 120 patients seen at the Sexually Transmitted Diseases unit of the Sanitary Dermatology Outpatient Clinic of Rio Grande do Sul. The serum from none of the patients was positive for human T-lymphotropic virus type 1 or type 2. Viral warts were the most frequent diagnosis. Drug use was confirmed as a risk factor and high educational levels were found to be a protective factor against Sexually Transmitted Diseases. Keywords: Sexually Transmitted Diseases; Risk Factors; Human T-lymphotropic virus type I; Human T-lymphotropic virus type II According to the recommended by the Ministry of Health of Brazil, when people with clinical signs of Sexually Transmitted Diseases (STDs) seek health services, they are tested for human immunodeficiency virus (HIV), syphilis, hepatitis B virus and hepatitis C virus. However, according to the local epidemiological context, there is not enough data to affirm the need of testing for human T-lymphotropic virus type I and II (HTLV-1 and -2). The serologic diagnosis of HTLV-1 and -2 infections could make the identification of new cases of subclinical infection possible and potentially aid in the management of possible clinical manifestations that are attributable to virus. Moreover, it could serve as a warning sign regarding the importance of STD and HTLV coinfection.
This is a contemporary cross-sectional study with control. We evaluated patients covered by the Unified Health System and seen at the STD unit of Sanitary Dermatology Outpatient Clinic of the State of Rio Grande do Sul.
This study was approved by the Research Ethics Committee of the Federal University of Halth Sciences of Porto Alegre and all patients signed an informed consent form. We used convenience sampling. Categorical data were analyzed using the chi-square test (with or without Yates' correction) or Fisher's exact test. Comparing the groups, the unadjusted odds ratios (ORs) with 95% confidence intervals (95% CI) were calculated by measuring the association between the variables of interest. Logistic regression was performed to adjust the estimates of the potentially associated factors. A value of p <0.05 was considered statistically significant, with 80% power.
Inclusion criteria were: patients with clinical symptoms of sexually transmitted infections, classified according to the syndromic approach into genital ulcers, urethral discharge, vaginal discharge, pelvic pain and genital warts. All patients were tested for HTLV-1 and -2 using the ELISA test (EnzymeLinkedImmunoSorbentAssay). A control group was formed in order to benchmark the results of the HTLV serology (blood donors of the blood bank of the Hospital Santa Casa de Porto Alegre). This happened at the same period as data collection, in August 2011 and April 2012.
The variables studied were age, gender, educational level, city of residence, syndromic diagnosis of STDs, serology for HTLV-1 and -2, serology for syphilis, use of drugs and/or alcohol, history of STD/HIV, history of previous serological tests for STDs, condom use, having a steady sexual partner or multiple sexual partners, and partner's history of STD. Tables 1 and 2 show the main study data.
120 patients were included in the study. 56.7% were male. The mean age was 30.9 (± 13.3) years. The serum from none of the patients was positive for HTLV-1 and -2. 10% of patients had positive serology for syphilis. A higher level of education of eight years and more was associated with an increased use of condoms, when compared with lower levels of education (p <0.05). Drug use was associated with positive serology for HIV, genital ulcers and urethral discharge (p <0.05).
Genital warts were the most frequently diagnosed STD (48.3%), revealing the importance of infections caused by papilloma virus (HPV).
The mean seroprevalence of HTLV-1 and -2 in Brazil is 0.5%, with higher prevalence in the North and Northeast and lower prevalence in the South of the country. 2, 3 In Porto Alegre, the prevalence among blood donors is 0.17%. 2 On the other hand, the seroprevalence of syphilis (10%) was very high, when compared with blood donors used as controls (0.5%).
We found a high consumption of licit and illicit drugs (over 75%) among the participants. There was a significant association between all STDs and the use of at least one type of drug.
A study conducted with adolescents in Ceará demonstrated the influence of alcohol on risk behavior STDs. 4, 5 In our study, the use of drugs was associated with multiple sexual partners and with urethral discharge. High levels of HTLV infection relate to the use of drugs and to relationships with drug users. 6, 7 A study conducted in 2005 showed that 2.4% of HIV patients were seropositive for HTLV. The use of intravenous cocaine was the most important risk factor. 7 It is known that low educational levels are associated with a higher prevalence of HTLV-1 and syphilis. 8, 9 In this study, most participants had an educational level of eight years study or more, and this was associated with the frequent use of condoms. Genital warts were more prevalent in individuals with higher educational levels. This finding may be related to greater concern about health and an increased demand for health care. 
